O. Keller

3.2k total citations · 1 hit paper
14 papers, 1.8k citations indexed

About

O. Keller is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, O. Keller has authored 14 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in O. Keller's work include Amyotrophic Lateral Sclerosis Research (3 papers), Neurological diseases and metabolism (2 papers) and Alzheimer's disease research and treatments (2 papers). O. Keller is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (3 papers), Neurological diseases and metabolism (2 papers) and Alzheimer's disease research and treatments (2 papers). O. Keller collaborates with scholars based in Czechia, Germany and Austria. O. Keller's co-authors include Irfan Gunduz, Stephan Waack, Ashley Hayes, Mario Stanke, Burkhard Morgenstern, Robert Rusina, Petr Ridzoň, L Fialová, Aleš Bartoš and Radoslav Matěj and has published in prestigious journals such as Nucleic Acids Research, Neurology and International Journal of Cancer.

In The Last Decade

O. Keller

13 papers receiving 1.8k citations

Hit Papers

AUGUSTUS: ab initio prediction of alternative transcripts 2006 2026 2012 2019 2006 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Keller Czechia 8 1.1k 723 356 223 181 14 1.8k
Philippe Brottier France 15 1.1k 1.0× 823 1.1× 367 1.0× 229 1.0× 310 1.7× 18 2.6k
Maja Tarailo‐Graovac Canada 20 2.1k 2.0× 1.1k 1.5× 945 2.7× 234 1.0× 269 1.5× 58 3.3k
Hua Wu China 22 702 0.7× 618 0.9× 314 0.9× 160 0.7× 278 1.5× 40 1.6k
Barry Moore United States 21 1.8k 1.7× 881 1.2× 825 2.3× 271 1.2× 219 1.2× 36 2.9k
Eric Ross United States 17 1.8k 1.7× 915 1.3× 359 1.0× 291 1.3× 198 1.1× 40 2.7k
C.K. Watanabe Japan 6 1.1k 1.0× 615 0.9× 296 0.8× 144 0.6× 95 0.5× 9 1.7k
Alexander Poliakov United States 10 1.9k 1.7× 801 1.1× 478 1.3× 208 0.9× 227 1.3× 16 2.5k
Jeannine D. Gocayne United States 7 1.4k 1.3× 366 0.5× 388 1.1× 95 0.4× 79 0.4× 9 2.0k
Michael Regulski United States 24 1.5k 1.4× 987 1.4× 427 1.2× 211 0.9× 105 0.6× 34 2.4k
Vydianathan Ravi Singapore 19 944 0.9× 341 0.5× 343 1.0× 120 0.5× 123 0.7× 30 1.5k

Countries citing papers authored by O. Keller

Since Specialization
Citations

This map shows the geographic impact of O. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Keller more than expected).

Fields of papers citing papers by O. Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Keller. The network helps show where O. Keller may publish in the future.

Co-authorship network of co-authors of O. Keller

This figure shows the co-authorship network connecting the top 25 collaborators of O. Keller. A scholar is included among the top collaborators of O. Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Keller. O. Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Keller, O., et al.. (2021). Observational cohort study of pericarditis associated to COVID-19 affection. Archives of Cardiovascular Diseases Supplements. 13(1). 165–165. 1 indexed citations
2.
Matěj, Radoslav, Gábor G. Kovács, Jiří Keller, et al.. (2012). Genetic Creutzfeldt–Jakob disease with R208H mutation presenting as progressive supranuclear palsy. Movement Disorders. 27(4). 476–479. 17 indexed citations
3.
Rusina, Robert, et al.. (2012). Peripheral neuropathy in Whipples disease: a case report.. PubMed. 48(2). 97–9. 2 indexed citations
4.
Bednařík, Josef, Zdeněk Ambler, J Opavský, et al.. (2011). Klinický standard pro farmakoterapii neuropatické bolesti. Česká a slovenská neurologie a neurochirurgie. 75(1). 9 indexed citations
5.
Keller, Jiří, Josef Vymazal, Petr Ridzoň, et al.. (2011). Quantitative brain MR imaging in amyotrophic lateral sclerosis. Magnetic Resonance Materials in Physics Biology and Medicine. 24(2). 67–76. 10 indexed citations
6.
Fialová, L, Jana Švarcová, Aleš Bartoš, et al.. (2009). Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis. European Journal of Neurology. 17(4). 562–566. 40 indexed citations
7.
Rusina, Robert, Petr Ridzoň, Petr Kulišťák, et al.. (2009). Relationship between ALS and the degree of cognitive impairment, markers of neurodegeneration and predictors for poor outcome. A prospective study. European Journal of Neurology. 17(1). 23–30. 46 indexed citations
8.
Keller, O., et al.. (2008). Soziale Auswirkungen des Morbus Crohn. DMW - Deutsche Medizinische Wochenschrift. 108(25). 971–975. 1 indexed citations
9.
Stanke, Mario, O. Keller, Irfan Gunduz, et al.. (2006). AUGUSTUS: ab initio prediction of alternative transcripts. Nucleic Acids Research. 34(Web Server). W435–W439. 1642 indexed citations breakdown →
10.
Keller, O.. (2005). Tenzní bolesti hlavy. Interní medicína pro praxi. 4(11). 14–15.
11.
Seeman, Pavel, et al.. (2004). Hearing loss as the first feature of late-onset axonal CMT disease due to a novel P0 mutation. Neurology. 63(4). 733–735. 24 indexed citations
12.
Tonus, Carolin, et al.. (1996). Kolorektales karzinom. Langenbeck s Archives of Surgery. 381(5). 251–7. 6 indexed citations
14.
Clarkson, B, et al.. (1967). Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.. PubMed. 27(11). 2129–36. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026